Table 3 Week 16: changes from baseline of the cardinal motor symptoms scores according to gender.
From: The effects of safinamide according to gender in Chinese parkinsonian patients
Parameter | Gender | Difference safinamide-placebo, LS mean (SE) | 95% CI | p-value† (entire cohort as compared to baseline) |
|---|---|---|---|---|
Tremor | F | − 1.067 (0.487) | − 2.028, − 0.106 | 0.005 |
M | − 0.746 (0.412) | − 1.557, − 0.066 | ||
Bradykinesia | F | − 1.559 (0.707) | − 2.951, − 0.166 | 0.0013 |
M | − 1.446 (0.597) | − 2.622, − 0.270 | ||
Rigidity | F | − 0.984 (0.526) | − 2.020, 0.052 | 0.0016 |
M | − 1.227 (0.445) | − 2.104, − 0.348 | ||
PIGD | F | − 0.241 (0.382) | − 0.994, 0.512 | 0.1535 |
M | − 0.478 (0.324) | − 1.117, 0.160 |
